IP Library Granted Patent US 12,442,009
Granted Patent B2
US 12,442,009 · App. 16/472,742 · Granted Oct 14, 2025

Sulfite tolerance in recombinant yeast host cells

Inventors: Aaron Argyros (Lebanon, NH); Charles F. Rice (Plainfield, NH); Trisha Barrett (Bradford, VT); Michelle Oeser (Croydon, NH); Janet Fisher (Norwich, VT)
Assignee: DANSTAR FERMENT AG
C12N15/81C12N1/185C12R2001/865
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,442,009
App. No.
16/472,742
Granted
Oct 14, 2025
Kind
B2
Abstract

The present disclosure concerns the use of specific genetic modification(s) for improving sulfite tolerance in recombinant yeast host cells. The genetic modification(s) is (are) designed to allow the expression of an heterologous transcription factor favoring the expression of a SSU1 polypeptide and/or the expression of an heterologous SSU1 polypeptide in the recombinant yeast host cell(s).

Claims (35)

1. A recombinant yeast host cell comprising:

(i) at least one first genetic modification selected from the group consisting of:

a heterologous nucleic acid molecule encoding a heterologous STL1 polypeptide, and

a heterologous nucleic acid molecule encoding a heterologous glucoamylase, wherein the heterologous glucoamylase comprises:

(i) the amino acid sequence of any one of SEQ ID NO: 13, 14, 15, 16, 17, 18, and 19,

(ii) a variant having at least 70% identity with the amino acid sequence of any one of SEQ ID NO: 13, 14, 15, 16, 17, 18, and 19, or

(iii) a fragment of (i) or (ii) having at least 70% identity with the amino acid sequence of any one of SEQ ID NO: 13, 14, 15, 16, 17, 18, and 19,

wherein the variant or the fragment has glucoamylase activity; and

(ii) at least one second genetic modification selected from the group consisting of:

a heterologous nucleic acid molecule encoding a heterologous transcription factor FZF1 polypeptide, wherein the heterologous transcription factor FZF1 polypeptide comprises:

(i) the amino acid sequence of any one of SEQ ID NO: 1 to 6, 21 and 22,

(ii) a variant having at least 70% identity with the amino acid sequence of any one of SEQ ID NO: 1 to 6, 21 and 22, or

(iii) a fragment of (i) or (ii) having at least 70% identity with the amino acid sequence of any one of SEQ ID NO: 1 to 6, 21 and 22,

wherein the variant or the fragment of the heterologous transcription factor FZF1 polypeptide favors the expression of a native SSU1 polypeptide, the heterologous SSU1 polypeptide, or both the native SSU1 polypeptide and the heterologous SSU1 polypeptide; and

a heterologous nucleic acid molecule encoding a heterologous SSU1 polypeptide, wherein the heterologous SSU1 polypeptide comprises:

(i) the amino acid sequence of any one of SEQ ID NO: 7 to 12, 23, 24, and 25,

(ii) a variant having at least 70% identity with the amino acid sequence of any one of SEQ ID NO: 7 to 12, 23, 24, and 25, or

(iii) a fragment of (i) or (ii) having at least 70% identity with the amino acid sequence of any one of SEQ ID NO: 7 to 12, 23, and 24,

wherein the variant or the fragment has sulfite efflux activity.

2. The recombinant yeast host cell of claim 1 having the heterologous nucleic acid molecule encoding the heterologous transcription factor FZF1 polypeptide.

3. The recombinant yeast host cell of claim 2 , wherein the heterologous transcription factor FZF1 polypeptide is expressed under the control of a constitutive, a glucose-regulated or a sulfite-regulated promoter.

4. The recombinant yeast host cell of claim 3 , wherein the promoter is (i) the glucose-regulated promoter, wherein the glucose-regulated promoter is the promoter of a hxt7 gene (hxt7p) or (ii) the sulfite-regulated promoter, wherein the sulfite-regulated promoter is the promoter of a gpd2 gene (gpd2p), the promoter of a fzf1 gene (fzf1p), the promoter of a ssu1 gene (ssu1p) or the promoter of a ssu1-r gene (ssur1-rp).

5. The recombinant yeast host cell of claim 2 , wherein the heterologous transcription factor FZF1 polypeptide is from a species of genus Saccharomyces.

6. The recombinant yeast host cell of claim 1 having the heterologous nucleic acid molecule encoding the heterologous SSU1 polypeptide.

7. The recombinant yeast host cell of claim 6 , wherein the heterologous SSU1 polypeptide is (i) a polypeptide encoded by a ssu1 gene ortholog, and/or (ii) expressed under control of a constitutive, a glucose-regulated or a sulfite-regulated promoter.

8. The recombinant yeast host cell of claim 6 , wherein the heterologous SSU1 polypeptide is from a species of genus Saccharomyces.

9. The recombinant yeast host cell of claim 1 , having the heterologous nucleic acid molecule encoding the heterologous STL1 polypeptide.

10. The recombinant yeast host cell of claim 1 having the heterologous nucleic acid molecule encoding the heterologous glucoamylase.

11. The recombinant yeast host cell of claim 1 , further comprising a third genetic modification for reducing the production of the one or more native enzymes that function to catabolize formate.

12. The recombinant yeast host cell of claim 1 being from a species of genus Saccharomyces.

13. The recombinant yeast host cell of claim 12 being from the species Saccharomyces cerevisiae.

14. A method of improving a growth property of a recombinant yeast host cell, said method comprising:

(i) providing a first recombinant yeast host cell having the first genetic modification defined in claim 1 ; and

(ii) introducing the second genetic modification defined in claim 1 in the first recombinant yeast host cell to provide a second recombinant yeast host cell,

wherein the growth property of the second recombinant yeast host cell is improved with respect to the growth property of the first recombinant yeast host cell.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2024
From: LALLEMAND HUNGARY LIQUIDITY MANAGEMENT LLC
To: DANSTAR FERMENT AG
Reel/Frame 068174/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2019
From: ARGYROS, AARON; RICE, CHARLES F.; BARRETT, TRISHA; OESER, MICHELLE; FISHER, JANET
To: LALLEMAND HUNGARY LIQUIDITY MANAGEMENT LLC
Reel/Frame 050893/0848 →
Continuity (2)
Provisional Application 62438391 · Dec 22, 2016
Related Publication 20220090102A1 · Mar 24, 2022
References Cited (17)
US 8956851B2 · Argyros et al. · 2015 [cited by applicant]
WO 2011140386A2 · 2011 [cited by applicant]
WO 2011153516A2 · 2011 [cited by applicant]
WO 2012138942A1 · 2012 [cited by applicant]
WO 2014144210A2 · 2014 [cited by applicant]
WO 2015023989A1 · 2015 [cited by applicant]
WO 2017037614A1 · 2017 [cited by applicant]
Davos et al., (Proteins: Structure, Function and Genetics, 2000, vol. 41: 98-107. [cited by examiner]
Wristlock et al., (Quarterly Reviews of Biophysics 2003, vol. 36 (3): 307-340. [cited by examiner]
Kwiatkowski et al., (Biochemistry 38:11643-11650, 1999. [cited by examiner]
Kisselev L., (Structure, 2002, vol. 10: 8-9. [cited by examiner]
Avram et al., “Fzf1p of [cited by applicant]
Avram et al., “SSU1 Encodes a Plasma Membrane Protein with a Central Role in a Network of Proteins Conferring Sulfite Tolerance in [cited by applicant]
Nardi et al., “A sulphite-inducible form of the sulphite efflux gene SSU1 in a [cited by applicant]
Nevoigt, “Progress in Metabolic Engineering of [cited by applicant]
Pagliardini et al., “The metabolic costs of improving ethanol yield by reducing glycerol formation capacity under anaerobic conditions in [cited by applicant]
Park et al., “SSU1 mediates sulphite efflux in [cited by applicant]